Dynamic Talk Session 2 : Harnessing new pricing models and contracting types to boost product access and affordability
- After download go to: Resource Library
- Speakers: Axel Boehnke - Director Market Access Europe North - PTC Therapeutics; Richard Rahul, Senior Manager, Monitor Deloitte; Libor Minichbauer, Director of Access and Pricing, Novartis Oncology EGM
- Free Video: No
- VLT Viewable: Yes
- https://storage.googleapis.com/epp-content/dynamic%20talks/2021/BannerLI_DT_LS_2021_20MAY_3.jpg
- https://storage.googleapis.com/epp-content/dynamic%20talks/2021/EPP%20Dynamic%20Talks%20LS-2.mp4
During these Dynamic Talks, 3 top experts will bring crystal ball sessions (3×20’) bringing answers to relevant discussions that are going on ;
- Assessing top barriers for value-based pricing adoption in pharma. What are the challenges facing value-based pricing implementation? How can we achieve a worthy transition to outcomes-based contracts?
- Exploring alternative pricing and contracting models for next generation therapies. What are the main tendencies for contracting preferences based on the product value? How can the industry successfully manage the challenges in ATMPs pricing settings and reimbursements?
- Indication-based pricing of innovative medicines – pragmatic or idealistic?
2021, Life Sciences, Recorded Dynamic Talks
- Hits: 361